Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (25)
Elena Puris, Gert Fricker & Mikko Gynther. (2023) The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy. Pharmaceutics 15:2, pages 364.
Crossref
Crossref
Fangrui Xiu, Magdalena Rausch, Zhibo Gai, Shanshan Su, Shijun Wang & Michele Visentin. (2023) The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug–Drug Interactions of Tyrosine Kinase Inhibitors. International Journal of Molecular Sciences 24:3, pages 2101.
Crossref
Crossref
YINGYING WANG, YING ZHOU, YU WANG, LUSHAN YU & SU ZENG. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
573
603
.
Narayan Acharya & Kamaleshwar P. Singh. (2022) Recent advances in the molecular basis of chemotherapy resistance and potential application of epigenetic therapeutics in chemorefractory renal cell carcinoma. WIREs Mechanisms of Disease 14:6.
Crossref
Crossref
Shiwei Zhou & Yan Shu. (2022) Transcriptional Regulation of Solute Carrier Drug Transporters. Drug Metabolism and Disposition 50:9, pages 1238-1250.
Crossref
Crossref
Ching-Feng Chiu, Ji Min Park, Hsin-Hua Chen, Chen-Zou Mau, Pai-Sheng Chen, Yen-Hao Su, Hsin-An Chen, Yun-Ru Liu, Tsung-Han Hsieh, Chien-Chao Chiu, Shao-Wen Hung, Cheng-Yi Kuo, Young-Mao Chen & Chi-Fen Chang. (2022) Organic cation transporter 2 activation enhances sensitivity to oxaliplatin in human pancreatic ductal adenocarcinoma. Biomedicine & Pharmacotherapy 153, pages 113520.
Crossref
Crossref
Kim L.R. Brouwer, Raymond Evers, Elizabeth Hayden, Shuiying Hu, Cindy Yanfei Li, Henriette E. Meyer zu Schwabedissen, Sibylle Neuhoff, Stefan Oswald, Micheline Piquette‐Miller, Chitra Saran, Noora Sjöstedt, Jason A. Sprowl, Simone H. Stahl & Wei Yue. (2022) Regulation of Drug Transport Proteins—From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. Clinical Pharmacology & Therapeutics 112:3, pages 461-484.
Crossref
Crossref
Carla Pou Casellas, Katja Jansen, Maarten B. Rookmaaker, Hans Clevers, Marianne C. Verhaar & Rosalinde Masereeuw. (2022) Regulation of solute carriers oct2 and OAT1/3 in the kidney: a phylogenetic, ontogenetic, and cell dynamic perspective. Physiological Reviews 102:2, pages 993-1024.
Crossref
Crossref
Jiayi Yin, Fengcheng Li, Zhaorong Li, Lushan Yu, Feng Zhu & Su Zeng. (2022) Feature, Function, and Information of Drug Transporter–Related Databases. Drug Metabolism and Disposition 50:1, pages 76-85.
Crossref
Crossref
Philip Sandoval & Bruno Hagenbuch. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
585
607
.
Alejandra Fernandez, Connor O’Leary, Kenneth J O’Byrne, Joshua Burgess, Derek J Richard & Amila Suraweera. (2021) Epigenetic Mechanisms in DNA Double Strand Break Repair: A Clinical Review. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Yaodong Yi, Liping Li, Feifeng Song, Ping Li, Mingyang Chen, Shixin Ni, Hengbin Zhang, Hui Zhou, Su Zeng & Huidi Jiang. (2021) L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity. Toxicology 459, pages 152853.
Crossref
Crossref
Ying Zhou, Wen Sun, Zhiyuan Qin, Suhang Guo, Yu Kang, Su Zeng & Lushan Yu. (2021) LncRNA regulation: New frontiers in epigenetic solutions to drug chemoresistance. Biochemical Pharmacology 189, pages 114228.
Crossref
Crossref
Yingying Wang, Qianying Zhu, Haihong Hu, Hong Zhu, Bo Yang, Qiaojun He, Lushan Yu & Su Zeng. (2021) Upregulation of histone acetylation reverses organic anion transporter 2 repression and enhances 5-fluorouracil sensitivity in hepatocellular carcinoma. Biochemical Pharmacology 188, pages 114546.
Crossref
Crossref
Zhenzhen Jiang, Xiaoli Zheng, Weijia Wang, Liqing Qiu, Lingrong Yang, Mingfeng Jiang & Yuhui Hua. (2021) CYP2C9 inhibits the invasion and migration of esophageal squamous cell carcinoma via downregulation of HDAC. Molecular and Cellular Biochemistry 476:5, pages 2011-2020.
Crossref
Crossref
Javier C. Angulo, Claudia Manini, Jose I. López, Angel Pueyo, Begoña Colás & Santiago Ropero. (2021) The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments. Cancers 13:9, pages 2071.
Crossref
Crossref
Jeffrey Y. W. Mak, Kai-Chen Wu, Praveer K. Gupta, Sheila Barbero, Maddison G. McLaughlin, Andrew J. Lucke, Jiahui Tng, Junxian Lim, Zhixuan Loh, Matthew J. Sweet, Robert C. Reid, Ligong Liu & David P. Fairlie. (2021) HDAC7 Inhibition by Phenacetyl and Phenylbenzoyl Hydroxamates. Journal of Medicinal Chemistry 64:4, pages 2186-2204.
Crossref
Crossref
Chunyan Jia, Glen B. Deacon, Yingjie Zhang & Chuanzhu Gao. (2021) Platinum(IV) antitumor complexes and their nano-drug delivery. Coordination Chemistry Reviews 429, pages 213640.
Crossref
Crossref
Jizhao Wang, Yuchen Sun, Xing Zhang, Hui Cai, Cheng Zhang, Hangying Qu, Lin Liu, Mingxin Zhang, Junke Fu, Jia Zhang, Jiansheng Wang & Guangjian Zhang. (2021) Oxidative stress activates NORAD expression by H3K27ac and promotes oxaliplatin resistance in gastric cancer by enhancing autophagy flux via targeting the miR-433-3p. Cell Death & Disease 12:1.
Crossref
Crossref
Seong Hwi Hong, Jiyoung Lee, Eun Bi Jang, Sung Yul Park, Hong-Sang Moon & Young Eun Yoon. (2020) Epigenetic Approaches to the Treatment of Renal Cell Cancer. The Korean Journal of Urological Oncology 18:2, pages 78-90.
Crossref
Crossref
Minjeong Yeon, Youngmi Kim, Hyun Suk Jung & Dooil Jeoung. (2020) Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Ying Zhou, Chaonan Ye, Yan Lou, Junqing Liu, Sheng Ye, Lu Chen, Jinxiu Lei, Suhang Guo, Su Zeng & Lushan Yu. (2020)
Epigenetic Mechanisms Underlying Organic Solute Transporter
β
Repression in Colorectal Cancer
. Molecular Pharmacology 97:4, pages 259-266.
Crossref
Crossref
Jiabei Zhou, Yu Kang, Lu Chen, Hua Wang, Junqing Liu, Su Zeng & Lushan Yu. (2020) The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents. Frontiers in Pharmacology 11.
Crossref
Crossref
Jiayi Yin, Wen Sun, Fengcheng Li, Jiajun Hong, Xiaoxu Li, Ying Zhou, Yinjing Lu, Mengzhi Liu, Xue Zhang, Na Chen, Xiuping Jin, Jia Xue, Su Zeng, Lushan Yu & Feng Zhu. (2020) VARIDT 1.0: variability of drug transporter database. Nucleic Acids Research 48:D1, pages D1042-D1050.
Crossref
Crossref
Paul Noordhuis, Adrianus C. Laan, Kasper van de Born, Richard J. Honeywell & Godefridus J. Peters. (2019) Coexisting Molecular Determinants of Acquired Oxaliplatin Resistance in Human Colorectal and Ovarian Cancer Cell Lines. International Journal of Molecular Sciences 20:15, pages 3619.
Crossref
Crossref